S
Simulations Plus
Providing software and consulting to accelerate drug discovery and development
At a glance
- Status
- Listed
- Founded
- 1996
- Headquarters
- Durham, United States
- Listing
- IPO 1997
- Sector
- Biotech & Life Sciences
- Outcome tier
- Colt$25–100M revenue
Knowledge graph
News
More headlines
Open roles
Simulations Plus in the Durham ecosystem
The Simulations Plus office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Investments and acquisitions
Disclosed deals where Simulations Plus was the backer or acquirer, 2014–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
6 deals across Simulations Plus's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Simulations Plus's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Simulations Plus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Simulations Plus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

